Pharmaceutical compositions
USRE38628E1 · kind E1 · reissue
Assignee
Inventors
Key dates
| Filing date | Aug 22, 1997 |
| Grant date | Oct 19, 2004 |
| Priority date | — |
| Expiry date | Aug 22, 2017 |
Classification
- Technology area (CPC —)General
Abstract
A method of treatment of a condition selected from the group comprising conjunctivitis, keratitis, ‘allergic eyes’, adenovirus infections, corneal homograft rejection, anterior uveitis, nasal polyps, vasomotor rhinitis, allergic manifestations of the nasopharynx, reversible obstructive airways disease, Crohn's disease, distal colitis and proctitis, which method comprises administration to a patient suffering from such a condition of a therapeutically effective amount of an aqueous solution containing, as active ingredient, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid or a pharmaceutically acceptable salt thereof. Also described are novel pharmaceutical compositions suitable for use in such methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.